ArticleEuropean journal of pharmacology2014

Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model.

Branden A Smeester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.